GJB5 and breast cancer: Other interesting factors emerged, such as ADAMDEC1 (FC = 8.23; FDR = 9.75 × 10−2), whose expression was shown to be associated with increased chemosensitivity and an improved prognosis in patients with breast cancer, and gap junctional protein GJB5, which is generally considered tumor suppressive.31 We observed no significant pathway enrichment in association with social support.